UnitedHealth is back under the regulatory spotlight, with fresh scrutiny of its Medicare business arriving just as investors are still digesting earlier legal and political blows. The new accusations ...

As 2026 approaches, financial concerns loom for many Americans, particularly those relying on Medicare Advantage for healthcare coverage. UnitedHealth, the largest healthcare provider in the U.S., has ...

Ballad Health is suing UnitedHealth for allegedly gaming the Medicare Advantage program, damaging patients and hospitals — particularly those in rural areas. The lawsuit filed in Tennessee district ...

UnitedHealth Group expects its Medicare Advantage enrollment will shrink by 1 million people next year, as the insurer trims offerings across the country while focusing on higher profit margins as the ...

UnitedHealth said it will stop offering Medicare Advantage plans in 109 U.S. counties in 2026, impacting 180,000 members, as the company balances higher costs with reimbursement pressure in the ...

UnitedHealth expects about 78% of its members to be enrolled in top-rated Medicare insurance plans next year, in line with its expectations, the top U.S. health insurer said in a filing on Tuesday.

Medicare Advantage insurers leaving certain markets affected more than 1 in 10 Americans enrolled in such plans with prescription drug coverage, a KFF analysis shows.

UnitedHealth Group Inc. used "aggressive strategies" to maximize diagnoses and boost payments for patients on private Medicare health plans, a new Senate report found, adding to pressure on the ...

UnitedHealth Group’s (UNH) insurance arm, UnitedHealthcare, on Wednesday announced a pilot program targeting independent rural hospitals to accelerate their Medicare Advantage payment timelines by 50% ...

It has been an unfortunate past few years for one of the country's largest healthcare companies, UnitedHealth Group (NYSE: UNH). There has been no shortage of bad PR, a changing business landscape, ...

For years, UnitedHealth Group (NYSE: UNH) stock has been a terrific growth investment. In fact, it looked unstoppable. Not ...